Epilepsy Clinical Trial
Official title:
Noninvasive Language Mapping in Patients With Localization-Related Epilepsy
Verified date | April 4, 2013 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will examine how certain language skills, such as naming objects, understanding
spoken language and reading are organized in the brain and how they are affected by seizures.
People with epilepsy who are considering surgery and healthy volunteers who are right-handed
and between the ages of 7 and 55 may be eligible for this study. Participants undergo the
following procedures twice, and, in some cases, possibly three times, in two or three visits
of 2 to 4 hours each.
Neuropsychological tests: Testing includes questionnaires, pen-and-pencil or computerized
tests and motor tasks.
Structural MRI: This procedure uses a strong magnetic field and radio waves to obtain
pictures of brain structure. During the test, the subject lies in the scanner (a metal
cylinder surrounded by a magnetic field) for about 90 minutes, wearing earmuffs to muffle
knocking noises the machine makes. Subjects may be asked to lie still for up to 10 minutes at
a time.
Functional MRI: This procedure is similar to structural MRI, except a coil is placed over the
head and the subject performs simple tasks during the procedure. The pictures obtained show
what parts of the brain are being used to perform the task. The test lasts about 60 minutes,
with subjects asked to lie still for up to 10 minutes at a time.
Magnetoencephalography (MEG) and electroencephalography (EEG): For MEG, the subject sits in
an MEG recording room with a cone containing magnetic field detectors lowered onto his or her
head. Very small magnetic changes produced by the activity of the brain are recorded while
the subject sits quietly or performs a research task. An EEG recording of the electrical
activity of the brain is done at the same time as the MEG.
...
Status | Completed |
Enrollment | 153 |
Est. completion date | April 4, 2013 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 7 Years to 55 Years |
Eligibility |
- INCLUSION CRITERIA FOR PATIENTS: 1. Age 7-55 2. Documentation of localization-related epilepsy based on clinical, neuropsychological and imaging criteria 3. Failure of seizures to respond to adequate therapy with at least two standard antiepileptic drugs 4. Willingness to be considered for surgery 5. Fluency in English. Non-native speakers may be included if their fluency is equivalent to that of a native speaker. INCLUSION CRITERIA FOR HEALTHY VOLUNTEERS: 1. Age 7-55 2. Willingness to participate in and complete the study 3. Right-handedness assessed by the Edinburg handedness inventory 4. Fluency in English EXCLUSION CRITERIA FOR PATIENTS: 1. Contra-indications to MRI studies (such as pacemakers, cochlear devices, surgical clips etc. metallic implants, orthopedic pins, shrapnel, permanent eyeliner, vagus nerve stimulator) 2. Claustrophobia or anxiety disorders exacerbated by the MRI scanner 3. People with neurological or psychiatric disease or taking medications that would affect fMRI and MEG language studies 4. Pregnancy. All females of child bearing potential must have a negative test prior to MRI scanning 5. Patients on phenobarbital or chronic benzodiazepines EXCLUSION CRITERIA FOR HEALTHY VOLUNTEERS: 1. Contra-indications MRI studies (metallic implants, recent orthopedic pins, cochlear implants, surgical clips, cardiac pacemakers and defibrillation devices, shrapnel, permanent eyeliner, vagus nerve stimulator) 2. Any medical condition or chronic medication that might affect fMRI or MEG language activation by affecting cerebral structure or function, such as diabetes, hypertension, antihypertensive medications, psychotropic agents. 3. Pregnancy. All females of child bearing potential must have a negative test prior to MRI scanning. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Berl MM, Balsamo LM, Xu B, Moore EN, Weinstein SL, Conry JA, Pearl PL, Sachs BC, Grandin CB, Frattali C, Ritter FJ, Sato S, Theodore WH, Gaillard WD. Seizure focus affects regional language networks assessed by fMRI. Neurology. 2005 Nov 22;65(10):1604-11. — View Citation
Binder JR, Swanson SJ, Hammeke TA, Morris GL, Mueller WM, Fischer M, Benbadis S, Frost JA, Rao SM, Haughton VM. Determination of language dominance using functional MRI: a comparison with the Wada test. Neurology. 1996 Apr;46(4):978-84. — View Citation
Brookes MJ, Vrba J, Robinson SE, Stevenson CM, Peters AM, Barnes GR, Hillebrand A, Morris PG. Optimising experimental design for MEG beamformer imaging. Neuroimage. 2008 Feb 15;39(4):1788-802. Epub 2007 Oct 10. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in asymmetry index of fMRI after surgery. | |||
Secondary | Changes in asymmetry index on MEG after surgery and seizure control after surgery. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A |